Chinese biotech firm WuXi plans to sell its Ireland facility to Merck for $500 million as the BioSecure Act advances through the Senate and awaits presidential approval.
WuXi Biotech Firm Sells Facility Ahead of US Legislation Ban
By NTD Newsroom
Chinese biotech firm WuXi plans to sell its Ireland facility to Merck for $500 million as the BioSecure Act advances through the Senate and awaits presidential approval.